Watch IRON. Know when insiders buy.
One email the day a filing lands. Free.
Work order
39
FLAG · insiders 25, shorts 52
Insiders, 90 days
−$5.1M
net selling · 0 buys, 10 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $3BP/E —DIV YIELD —FCF YIELD -6.50%REV TTM —NET INCOME −$245.9MNET CASH $39.3M52W 55.95 – 94.11SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$65.1M | −$59.5M | — | -1.54 | −$44.2M | $0 | −$44.2M | Jul 30 |
| Q1 2026 · Mar 31 | — | — | — | −$69.5M | −$63.5M | — | -1.65 | −$62.2M | $0 | −$62.2M | Jul 30 |
| Q4 2025 · Dec 31derived | — | — | — | −$67M | −$60.5M | — | -1.62 | −$43.3M | $20K | −$43.3M | Feb 26 |
| Q3 2025 · Sep 30 | — | — | — | −$67.7M | −$62.3M | — | -1.77 | −$47.8M | $26K | −$47.8M | Nov 6 |
| Q2 2025 · Jun 30 | — | — | — | −$61.4M | −$55.2M | — | -1.58 | −$47.9M | $36K | −$48M | Jul 30 |
| Q1 2025 · Mar 31 | — | — | — | −$39.9M | −$34.1M | — | -1.02 | −$41.4M | $851K | −$42.2M | Jul 30 |
| Q4 2024 · Dec 31derived | — | — | — | −$34.5M | −$29.5M | — | -0.98 | −$27.6M | $449K | −$28M | Feb 26 |
| Q3 2024 · Sep 30 | — | — | — | −$32.9M | −$26.6M | — | -0.89 | −$17.4M | −$8K | −$17.4M | Nov 6 |
| Q2 2024 · Jun 30 | — | — | — | −$30.9M | −$26.4M | — | -1.03 | −$15.4M | −$3K | −$15.4M | Nov 6 |
| Q1 2024 · Mar 31 | — | — | — | −$31.5M | −$26.9M | — | -1.09 | −$33.6M | $67K | −$33.7M | Nov 6 |
| Q4 2023 · Dec 31derived | — | — | — | −$29.7M | −$23.6M | — | -0.97 | −$17.8M | $3K | −$17.8M | Feb 26 |
| Q3 2023 · Sep 30 | — | — | — | −$19M | −$14.1M | — | -0.58 | −$7.5M | $45K | −$7.5M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$236M | −$212.2M | — | -6.01 | −$180.4M | $933K | −$181.3M | — | — |
| FY2024 · to Dec 31 | — | — | −$129.7M | −$109.4M | — | -3.96 | −$93.9M | $505K | −$94.4M | — | — |
| FY2023 · to Dec 31 | — | — | −$91.1M | −$76.4M | — | -3.42 | −$73.5M | $89K | −$73.6M | — | — |
| FY2022 · to Dec 31 | — | — | −$47.5M | −$46.8M | — | -45.05 | −$42.3M | $151K | −$42.4M | — | — |
| FY2021 · to Dec 31 | — | — | −$30.9M | −$36M | — | -40.95 | −$27.5M | $68K | −$27.6M | — | — |
| FY2020 · to Dec 31 | — | — | −$34M | −$40.8M | — | -2.70 | −$32.7M | $22K | −$32.7M | — | — |
Every number comes from Disc Medicine, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.